Back to the calendar
5th Annual Advances in Immuno-Oncology Congress
By Oxford Global Conferences

Over 350 attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic and healthcare institutions developing immuno-oncology therapies and tools.

Over 60 presentations, case studies and panel discussions focussed on the key opportunities and challenges in immuno-oncology, from therapeutic strategies and biomarker development through to clinical research.

PLUS, interactive opportunities including:
• Workshop on Accelerating the Treatment & Response Rate of Cancer Immunotherapies
• 6 roundtable discussions on key industry growth areas within immuno-oncology

View Agenda:

Day One – 21 May 2020
• Discovery of Immuno-Oncology Therapies: Inhibitory Pathway & Cell-Based Approaches
• Translational Immuno-Oncology
• Personalised Therapies for Immuno-Oncology

Day Two – 22 May 2020
• Discovery of Immuno-Oncology Therapies: Antibody and Virus-Based Approaches
• Preclinical Development: Screening, Assays and Modelling in Immuno-Oncology
• Clinical Research & Trials in Immuno- Oncology